Answers are grounded in this paper and cite their sources.
Observational analysis reveals challenges with pain relief in diabetic neuropathy, suggesting a need for better therapies.
High rates of treatment discontinuation and suboptimal adherence likely indicate challenges with tolerability and insufficient pain relief associated with current therapies for painful diabetic neuropathy. These findings emphasize the limitations of existing treatment options and highlight the unmet need for more effective and better-tolerated treatments for these patients.
No takes yet. Share an insight, caveat, or question.
Schuster et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: